The key findings are as follows: BCL2 was widely expressed across kidney tissue in DKD patients; however, its expression levels were significantly reduced in podocytes and tubular epithelial cells compared to other cell types (Figure 5B,C). Here, BCL2 is linked to diabetic kidney disease.